Lincoln Pharmaceuticals Share Price
Know More₹478.50 15.50 (3.35%)
04:01 PM, 3-Feb-2026₹478.30 13.30 (2.86%)
03:44 PM, 3-Feb-2026BSE : 531633
NSE : LINCOLN
Sector : Health care
ISIN Code : INE405C01035
- BSE
- NSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 03-Feb-2026 | 04:01 PM IST
| Market Cap (₹ Cr) | 958 |
Traded Value (₹ Cr) | 0.04 |
Volume (Shares) | 853 |
Face Value (₹) | 10 |
52-Week High (₹) | 804.70 |
52-Week High Date | 06-Feb-2025 |
52-Week Low (₹) | 439.95 |
52-Week Low Date | 28-Jan-2026 |
All Time High (₹) | 975.00 |
All Time High Date | 09-Dec-2024 |
All Time Low (₹) | 8.05 |
All Time Low Date | 12-Jun-2002 |
Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd News
Lincoln Pharma. Announcement
Lincoln Pharmaceuticals Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 958 |
| EPS - TTM (₹) [C] | 39.94 |
| P/E Ratio (X) [C] | 11.98 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | 18.00 |
| Latest Dividend Date | 12-Sep-2025 |
| Dividend Yield (%) | 0.38 |
| Book Value Share (₹) [C] | 357.35 |
| P/B Ratio (₹) [C] | 1.34 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 0.01 | 281 | 0.03 |
| Bandhan BSE Healthcare Index Fund - Regular (G) | 0.01 | 122 | 0.03 |
| Bandhan BSE Healthcare Index Fund - Direct (G) | 0.01 | 122 | 0.03 |
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 470.10 500.05 |
| Week Low/High (₹) | 440.00 500.05 |
| Month Low/High (₹) | 440.00 505.00 |
| Year Low/High (₹) | 440.00 809.00 |
| All time Low/High (₹) | 8.05 980.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 6.29% | 6.36% | 2.30% | 2.19% |
| 1 Month | -3.69% | -3.79% | -2.36% | -2.28% |
| 3 Month | -10.27% | -10.33% | -0.29% | -0.14% |
| 6 Month | -10.42% | -10.44% | 3.89% | 4.73% |
| 1 Year | -30.75% | -30.77% | 8.49% | 10.13% |
| 3 Year | 53.45% | 53.25% | 37.63% | 44.10% |
Company Info
Company Information
Chairman (Non-Executive) : Kishorbhai M Shah
Managing Director : Mahendra G Patel
Whole-time Director : Hasmukhbhai I Patel
Whole-time Director : Munjal Mahendrabhai Patel
Whole-time Director : Aashish R Patel
Independent Director : Saurin J Parikh
Non Executive Director : Rajnikant G Patel
Company Sec. & Compli. Officer : Trusha Shah
Independent Director : Seema Mehta
Independent Director : Nareshkumar Pirabhai Suthar
Registered Office: Lincoln House B/H Satyam Compe, Science City Road Sola,Ahmedabad,Gujarat-380060 Ph: 91-079-67778000
FAQs about Lincoln Pharmaceuticals Ltd
1. What's the Lincoln Pharmaceuticals Ltd share price today?
Lincoln Pharmaceuticals Ltd share price was Rs 478.50 at 04:01 PM IST on 3rd Feb 2026. Lincoln Pharmaceuticals Ltd share price was up by 3.35% over the previous closing price of Rs 463.00. Lincoln Pharmaceuticals Ltd share price trend:
- Last 1 Month: Lincoln Pharmaceuticals Ltd share price moved down by 3.69% on BSE.
- Last 3 Months: Lincoln Pharmaceuticals Ltd share price moved down by 10.27% on BSE.
- Last 12 Months: Lincoln Pharmaceuticals Ltd share price moved down by 30.75% on BSE.
- Last 3 Years: Lincoln Pharmaceuticals Ltd share price moved up by 53.45% on BSE.
2. How can I quickly analyse the performance of the Lincoln Pharmaceuticals Ltd stock?
The performance of the Lincoln Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 11.98
- Price to book value ratio is 1.34
- Dividend yield of 0.38
- The EPS (trailing 12 months) of the Lincoln Pharmaceuticals Ltd stock is Rs 39.94
3. What is the market cap of Lincoln Pharmaceuticals Ltd?
Lincoln Pharmaceuticals Ltd has a market capitalisation of Rs 958 crore.
4. What is Lincoln Pharmaceuticals Ltd's 52-week high/low share price?
The Lincoln Pharmaceuticals Ltd’s 52-week high share price is Rs 804.70 and 52-week low share price is Rs 439.95.
5. Is the Lincoln Pharmaceuticals Ltd profitable?
On a consolidated basis, Lincoln Pharmaceuticals Ltd reported a profit of Rs 19.98 crore on a total income of Rs 170.60 crore for the quarter ended 2025.
6. Which are Lincoln Pharmaceuticals Ltd’s peers in the Health care sector?
Lincoln Pharmaceuticals Ltd’s top 5 peers in the Health care sector are NGL Fine Chem, Bajaj Healthcare, Venus Remedies, Lincoln Pharma., Fermenta Biotec., Ind-Swift Labs., Fredun Pharma.
7. Who owns how much in Lincoln Pharmaceuticals Ltd?
Key changes to the Lincoln Pharmaceuticals Ltd shareholding are as follows:
- Promoter holding in Lincoln Pharmaceuticals Ltd has gone up to 49.78 per cent as of Dec 2025 from 49.78 per cent as of Mar 2025.